factual
Telemedicine Assessors Mitigated Unblinding
To minimize the unavoidable unblinding problem, the FDA and sponsor agreed on a study design using independent telemedicine assessors—anonymous, remote evaluators who never interacted with the participant and didn't know whether the person received placebo or active drug or what stage of the trial they were in—an option only available because the design happened to be finalized after Zoom-style platforms existed.
factualpending
Speaker
Jennifer MitchellEvidence Quote
“that way this this assessor doesn't know where this person's calling from if they thought they received placebo or active drug”
Created: 6/14/2026, 2:01:41 AM
Your notes
Loading notes...